Fig. 5From: PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse modelThe IFN-γ and IL-18 expression levels in the plasma was examined after different treatments using ELISA, *P < 0.05Back to article page